Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2007
10/10/2007EP1776369B1 Thienopyridone carboxamides and their medical use
10/10/2007EP1525200B1 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors
10/10/2007EP1511509B1 Compositions and methods for treating diabetes
10/10/2007EP1454897B1 Pyrazolopyrimidinone derivatives having pde7-inhibitory activity
10/10/2007EP1404295B1 Sustained release drug delivery devices with coated drug cores
10/10/2007EP1385882B1 Peptides and related molecules that bind to tall-1
10/10/2007EP1354884B1 Cyclopenta[d]pyrazolo[1,5-a]pyrimidine compound as crf receptor antagonist
10/10/2007EP1347990B1 Peptides having inhibiting activity to nitric oxyde production
10/10/2007EP1332132B1 Enamine derivatives as cell adhesion molecules
10/10/2007EP1319007B9 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
10/10/2007EP1272215B1 Pharmaceutical preparations comprising modified peptides
10/10/2007EP1249450B1 Benzimidazole derivatives as human chymase inhibitors
10/10/2007EP1232150B1 Urea derivatives as anti-inflammatory agents
10/10/2007EP1231927B1 Compositions comprising vernix and an uv protectant and their use
10/10/2007EP1183044B1 Adjuvant combinations for immunization and vaccines
10/10/2007EP1173195B1 UTEROGLOBIN IN THE TREATMENT OF IgA MEDIATED AUTOIMMUNE DISORDERS
10/10/2007EP0666760B2 VACCINE COMPRISING PART OF CONSTANT REGION OF IgE FOR TREATMENT OF IgE-MEDIATED ALLERGIC REACTIONS
10/10/2007CN101052654A Polypeptide variants with altered effector function
10/10/2007CN101052653A Anti-Fc-gamma RIIB receptor antibody and uses therefor
10/10/2007CN101052419A Antagonizing interleukin-21 receptor activity
10/10/2007CN101052418A Functional composition or food comprising whey protein and antibody derived from milk or antibody
10/10/2007CN101052415A Methods and compositions for treating and preventing inflammatory conditions
10/10/2007CN101049500A Composition of amino acid
10/10/2007CN101049491A Application of stomachic pill with cyperus and amomum
10/10/2007CN101049470A Preparation of Chinese traditional medicine for treating urticaria
10/10/2007CN101049339A Method for preparing injection of astragalus
10/10/2007CN101049335A Injection of general flavone of epimedium
10/10/2007CN101049328A Technique for producing extractive of olive growing leaves
10/10/2007CN101049323A Health protection medicine in use for treating chronic degenerative diseases, and producing method
10/10/2007CN101049320A Buccal tablets of extractive of propolis alcohol
10/10/2007CN101049141A Soup dishes of edible cactus
10/10/2007CN100342017C Gene recombined chemotaxis antigen vaccine
10/10/2007CN100341896C Anti-GP39 antibodies and uses therefor
10/10/2007CN100341575C Water soluble dry compositions
10/10/2007CN100341544C Health care product having immune regulating and antimutation action
10/10/2007CN100341528C Use of manchurian tuber gourd fruit extract for preparing analgesic, anti-inflammatory and/or anti-allergic medicine
10/10/2007CN100341525C Compositions and methods for treatment of diabetes
10/10/2007CN100341521C Composition containing beta-glucan and constipation-relieving drug, immunopotentiator and skin moistening agent using the composition
10/10/2007CN100341496C Preventive or therapeutic agent for kidney disease
10/10/2007CN100341416C Health food containing ampeloptin
10/10/2007CA2564435A1 Methods for monitoring and treating intestinal disorders
10/09/2007US7279593 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
10/09/2007US7279573 Benzodiazepine derivatives that may be fused to a pyrroline or piperidine ring; e.g., N-[1 (R)-(3-Aminopropylcarbamoyl)-2-(naphthalen-2-yl)ethyl]-3-(5,11-dioxo-2,3-dihydro-1H-(11aS)-pyrrolo[2,1-c][1,4]benzodiazepin-10-yl)propionamide; increasing levels of endogenous growth hormones in humans and animals
10/09/2007US7279567 Nucleotide sequences coding preferential polypeptide for use in the treatment defects in immune and inflammatory response
10/09/2007US7279560 Administering monoclonal antibodies to inhibit transmission of costimulatory signal of lymphocytes; antiallergens; autoimmune diseases
10/09/2007US7279550 For therapy of immune or autoimmune diseases
10/09/2007US7279484 Suppress tumor necrosis factor; Crohn's disease; imflammatory bowel disorders; sepsis; autoimmune disease
10/09/2007US7279482 Such as 6-(2-hydroxy-3-chloroxybenzylamino)purine, 6-(2-hydroxy-4-chlorobenzylamino)purine; agriculture; cloning; immunostimulation
10/09/2007US7279476 Anticancer agents, antiinflamamtory agents, restenosis, cardiovascular disorders; insertable device
10/09/2007US7279474 example compound: [7-(2,4-dichlorophenyl)-2-methyl-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl]-(1-ethyl-propyl)amine; treatment of irritable bowel disease and inflammatory bowel disease; anxiety; depression
10/09/2007US7279472 cathepsins inhibitors such as N-(4-Cyano-methyl-piperidin-4-yl)-3-cyclohexyl-2-(3-oxo-3H-isoindol-1-ylamino)-propionamide, used for treating autoimmune diseases such as arthritis, multiple sclerosis, asthma and osteoporosis
10/09/2007US7279331 Inducing differentiation of isolated marrow stromal cell into a neuronal cell using neuronal differentiation-inducing compound such as dimethylsulfoxide and butylated hydroxyanisole for treating nervous system disorders
10/09/2007US7279324 Nucleic acid encoding G-protein coupled receptor with modified DRY motif
10/09/2007US7279299 Contacting a candidate molecule with a polypeptide, Polypeptide retains the ability to dephosphorylate an activated MAP-kinase; detecting the presence or absence of binding of the candidate molecule to the polypeptide, and determining whether the candidate molecule interacts with the DSP-10 polypeptide
10/09/2007US7279175 Reduce restenosis coating on medical device
10/09/2007US7279170 Recombinant polypeptides, which can be used as purified antigens for the detection and control of tuberculosis
10/09/2007US7279169 A diphtheria toxoid, a tetanus toxoid, and a detoxified pertussis holotoxin; and a detoxified E. coli heat labile toxin that is is LT-K63 or LT-R72; is administered intranasally
10/09/2007US7279157 Treating with active material having heavy chain variable region of amino acid sequence 7 and light chain variable region of sequence 8; psoriasis, multiple sclerosis, Crohn's disease
10/09/2007US7279156 Apoptotic bodies and/or apoptotic cells are in a liquid suspension along with viable cells.
10/09/2007CA2252084C Cytoprotective compounds
10/09/2007CA2156416C Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus
10/06/2007WO2008125901A2 2-methylene-1alpha,25-dihydroxy-18,19,21-trinorvitamin d3 and uses thereof
10/04/2007WO2007111294A1 Histamine release inhibitor
10/04/2007WO2007111276A1 Novel ester derivative and use thereof
10/04/2007WO2007111227A1 Acylaminopiperidine compound
10/04/2007WO2007110761A2 Polymorphic forms of olopatadine hydrochloride and methods for producing olopatadine and salts thereof
10/04/2007WO2007110409A1 Compositions comprising a recombinant adenovirus and an adjuvant
10/04/2007WO2007110380A1 Insect bite relief preparation comprising epinastine
10/04/2007WO2007109825A1 Method for treating stage iv melanoma
10/04/2007WO2007084672A3 Monoclonal antibodies against cd30 lacking in fucosyl and xylosyl residues
10/04/2007WO2007063385A3 Spirocyclic amine histamine-3 receptor antagonists
10/04/2007WO2007059342A3 Random copolymer compositions for treating unwanted immune response
10/04/2007WO2007058568A3 Salts of 9-oxoacridine-10-acetic acid with 1-alkylamino-1-desoxy-polyols
10/04/2007WO2007042289A3 Nanobodies™ and polypeptides against egfr and igf-ir
10/04/2007WO2007038637A3 Human monoclonal antibodies to cd70
10/04/2007WO2006116156A3 Toxin peptides with extended blood halflife
10/04/2007WO2005039546A3 Use of indoleacetic acid derivatives which increase the serum igf-1 level for the preparation of a therapeutical composition for treatment of various diseases
10/04/2007WO2005032462A3 Glucocerebroside treatment of disease
10/04/2007US20070232798 Process For The Synthesis Of 2'-O-Substituted Pyrimidines And Oligomeric Compounds Therefrom
10/04/2007US20070232658 Protein Kinase C Inhibitors for the Treatment of Autoimmune Diseases and of Transplant Rejiction
10/04/2007US20070232647 Use of Ppar Agonists to Treat Ruminants
10/04/2007US20070232622 Small molecule toll-like receptor (TLR) antagonists
10/04/2007US20070232613 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 3-nitro- or 3-alkoxycarbonyl-1-methyl-4-[4-thiophene-2-carbonyl)-piperazine-1-yl]-1H-quinolin-2-one; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder
10/04/2007US20070232601 Vla-4 Inhibitor
10/04/2007US20070232586 Hydrazino-Substituted Heterocyclic Nitrile Compounds and Use Thereof
10/04/2007US20070232536 Pharmaceutical compositions containing plasma protein
10/04/2007US20070231863 Expression vector comprising nucleotide sequences coding homeobox gene for use in identifying modulators for treatment and prevention of nervous system and seizure disorders
10/04/2007US20070231830 Using competitive binding assays to identify peptide modulators for signal transduction
10/04/2007US20070231267 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
10/04/2007US20070231266 Diagnosis of macrophage mediated disease
10/04/2007DE102006015574A1 Active substance fraction from Rheum species, obtained by extracting Rheum root samples with methanol, separating lipophilic material and condensing the fraction, useful to treat and prevent e.g. inflammatory diseases
10/04/2007DE102006014390A1 Assoziate von Xanthogenaten mit Cyclodextrinen und ihre Verwendung Associates of xanthates with cyclodextrins and their use
10/04/2007CA2645791A1 Polymorphic forms of olopatadine hydrochloride and methods for producing olopatadine and salts thereof
10/04/2007CA2644369A1 Amide derivatives and their application for the treatment of g protein related diseases
10/03/2007EP1840135A1 Anti-alhpha 9 integrin antibody and the use thereof
10/03/2007EP1840132A2 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
10/03/2007EP1840125A2 Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
10/03/2007EP1839674A1 CD40 antagonist for treating psoriasis
10/03/2007EP1839673A2 Prevention and treatment of hypergastrinemia
10/03/2007EP1839648A2 An inhalation system
1 ... 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 ... 1172